Sale!

ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ALS2 gene. This gene is crucial because its mutations are known to cause a rare neurological disorder characterized by infantile-onset ascending spastic paralysis. This condition typically begins in the lower limbs and progressively affects the upper limbs and other body parts.

The test is crucial for early diagnosis and management of the disorder, helping healthcare professionals devise a suitable treatment and management plan for the affected individuals. The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for any mutations in the ALS2 gene.

At a cost of 4400 AED, this genetic test is a valuable resource for families seeking answers to unexplained symptoms of progressive muscle stiffness and weakness in their children. Early detection through this test can significantly impact the quality of life of the affected individuals by enabling timely interventions and supportive care. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing services for this rare genetic disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test

Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. In this blog post, we will discuss the ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test, including its components, cost, symptoms, diagnosis, and more.

Test Name: ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ALS2 Gene Spastic Paralysis Infantile Onset Ascending.

Test Details

ALS2 gene spastic paralysis, infantile onset ascending is a genetic disorder that affects the nervous system. It is caused by mutations in the ALS2 gene, which is responsible for producing a protein called alsin. This protein plays a crucial role in the development and maintenance of motor neurons, which control muscle movement.

Infantile onset ascending spastic paralysis is characterized by muscle stiffness and weakness that begins in infancy and worsens over time. The symptoms typically start in the legs and gradually spread to the arms and upper body. Affected individuals may also experience difficulties with coordination, speech, and swallowing.

NGS (Next Generation Sequencing) genetic testing is a powerful tool used to analyze multiple genes simultaneously. In the case of ALS2 gene spastic paralysis, NGS technology is employed to sequence the DNA and identify any mutations or changes in the ALS2 gene that may be causing the disorder.

This test not only confirms a diagnosis of ALS2 gene spastic paralysis but also provides valuable information about the specific mutation present. This information can be crucial for genetic counseling and family planning purposes.

The ALS2 gene spastic paralysis, infantile onset ascending NGS genetic test is a diagnostic tool that helps identify the underlying genetic cause of the disorder and provides essential information for managing the condition.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you suspect ALS2 gene spastic paralysis, we encourage you to consult with a neurologist and consider undergoing the ALS2 Gene Spastic Paralysis Infantile Onset Ascending Genetic Test.

Test Name ALS2 Gene Spastic paralysis infantile onset ascending Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALS2 Gene Spastic paralysis, infantile onset ascending NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ALS2 Gene Spastic paralysis, infantile onset ascending
Test Details

ALS2 gene spastic paralysis, infantile onset ascending is a genetic disorder that affects the nervous system. It is caused by mutations in the ALS2 gene, which is responsible for producing a protein called alsin. This protein is involved in the development and maintenance of motor neurons, which are the nerve cells that control muscle movement.

Infantile onset ascending spastic paralysis is characterized by muscle stiffness and weakness that starts in infancy and progressively worsens over time. The symptoms typically begin in the legs and then spread to the arms and upper body. Affected individuals may also experience difficulty with coordination, speech, and swallowing.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously. It involves sequencing the DNA to identify any mutations or changes in the ALS2 gene that may be causing the disorder. This test can help confirm a diagnosis of ALS2 gene spastic paralysis and may also provide information about the specific mutation present, which can be helpful for genetic counseling and family planning.

Overall, the ALS2 gene spastic paralysis, infantile onset ascending NGS genetic test is a diagnostic tool that can help identify the underlying genetic cause of the disorder and provide important information for managing the condition.